Regenerative Medical Solutions Inc — Department of Health and Human Services SBIR Phase I: ? DESCRIPTION (provided by applicant): Diabetes represents one of the most serious hea
Regenerative Medical Solutions Inc — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $222,020
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Solicitation
- PA14-071
- NAICS
- —
- Place of performance
- IL
- Period
- —
Description
? DESCRIPTION (provided by applicant): Diabetes represents one of the most serious health crises worldwide. It is estimated by the American Diabetes Association that one person is diagnosed with diabetes every 17 seconds, while the International Diabetes Federation states that one person dies every seven seconds from diabetes. Diabetes growth continues to skyrocket, with over 382 million cases worldwide, and according to the Centers of Disease Control, one out of every three Americans will have Type IIdiabetes by 2050. Replacement of deficient ? cells with human islets has proven successful in treating diabetes. Unfortunately, the high cost, unpredictable availability, and variable quality of human islets hinder wide spread application. Thus, an abundant supply of high-quality ?-like cells generated from human pluripotent stem cells (hPSCs) has tremendous implications for both therapeutic application and the development of drug discovery platforms. RMS has developed and marketed a novel in vitro differe